Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Alopecia areata involves immune system changes, especially in severe cases, with potential new treatment targets identified.

Mogamulizumab treatment in Sézary syndrome may cause skin issues and hair loss but can lead to a complete response.

Monoclonal antibodies LT-1, LT-2, and LT-7 help diagnose certain blood cancers.

Early investigation and a team approach are crucial for managing primary amenorrhea effectively.

Alopecia areata and myasthenia gravis can occur as rare symptoms of breast cancer.

Different diagnostic criteria greatly affect PCOS diagnosis rates in teenagers.

High levels of anti-Müllerian hormone can indicate polycystic ovarian syndrome in women who can have babies.

A SALT score of ≤ 20 indicates meaningful improvement in alopecia areata treatment.

The conclusion is that three signs can help diagnose hair loss after it happens, potentially avoiding more invasive tests.

Widened sweat ducts are a very specific sign of scarring hair loss.

Necrobiosis lipoidica may need new criteria for accurate diagnosis due to similarities with another condition.

A rare case of Cushing syndrome was successfully treated with one-sided adrenal gland removal, suggesting personalized treatment is important.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

The report described a unique case of Cronkhite-Canada syndrome with unusual polyps and an association with multiple myeloma.

Intralesional cidofovir may be a viable treatment for conjunctival lesions in Melkersson-Rosenthal syndrome without systemic toxicity.

Standardized data is essential for diagnosing scalp and hair conditions in males.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Hair transplantation is unsafe for diffuse unpatterned alopecia; focus on medical treatment and reassessment.

Renaming frontal fibrosing alopecia to a syndrome could improve diagnosis and treatment.

Researchers found a white halo around hair in most patients with a specific type of hair loss, which helps in early diagnosis and treatment.

Type 3 acromegaly patients have more health issues and higher death risk.

Patients and doctors often disagree on alopecia areata severity and treatment satisfaction.

No single biomarker is reliable enough for diagnosing and assessing SLE.

Most people who volunteered for a health study had medical issues, showing the need for careful screening before trials.

The DLQI is a key tool for measuring quality of life in dermatology.

Women with skin conditions who have body image concerns often experience mental health issues and a lower quality of life.

The study found that hair transplant surgery can be used to treat a rare condition that causes a band of hair loss, but surgeons should check for skull abnormalities first.

Patients with both connective tissue disease and acid reflux are more likely to have certain symptoms and physical signs.

Moth-eaten hair loss can be a sign of syphilis.

Alopecia areata patients may have higher cardiovascular risk factors, so screening for metabolic syndrome components is suggested.